Literature DB >> 19449045

Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing.

F Armougom1, F Bittar, N Stremler, J-M Rolain, C Robert, J-C Dubus, J Sarles, D Raoult, B La Scola.   

Abstract

Recent studies using 16S rRNA gene amplification followed by clonal Sanger sequencing in cystic fibrosis demonstrated that cultured microorganisms are only part of the infecting flora. The purpose of this paper was to compare pyrosequencing and clonal Sanger sequencing on sputum. The sputum of a patient with cystic fibrosis was analysed by culture, Sanger clone sequencing and pyrosequencing after 16S rRNA gene amplification. A total of 4,499 sequencing reads were obtained, which could be attributed to six consensus sequences, but the length of reads leads to fastidious data analysis. Compared to clonal Sanger sequencing and to cultivation results, pyrosequencing recovers greater species richness and gives a more reliable estimate of the relative abundance of bacterial species. The 16S pyrosequencing approach expands our knowledge of the microbial diversity of cystic fibrosis sputum. The current lack of phylogenetic resolution at the species level for the GS 20 sequencing reads will be overcome with the next generation of pyrosequencing apparatus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19449045     DOI: 10.1007/s10096-009-0749-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

2.  Genome sequencing in microfabricated high-density picolitre reactors.

Authors:  Marcel Margulies; Michael Egholm; William E Altman; Said Attiya; Joel S Bader; Lisa A Bemben; Jan Berka; Michael S Braverman; Yi-Ju Chen; Zhoutao Chen; Scott B Dewell; Lei Du; Joseph M Fierro; Xavier V Gomes; Brian C Godwin; Wen He; Scott Helgesen; Chun Heen Ho; Chun He Ho; Gerard P Irzyk; Szilveszter C Jando; Maria L I Alenquer; Thomas P Jarvie; Kshama B Jirage; Jong-Bum Kim; James R Knight; Janna R Lanza; John H Leamon; Steven M Lefkowitz; Ming Lei; Jing Li; Kenton L Lohman; Hong Lu; Vinod B Makhijani; Keith E McDade; Michael P McKenna; Eugene W Myers; Elizabeth Nickerson; John R Nobile; Ramona Plant; Bernard P Puc; Michael T Ronan; George T Roth; Gary J Sarkis; Jan Fredrik Simons; John W Simpson; Maithreyan Srinivasan; Karrie R Tartaro; Alexander Tomasz; Kari A Vogt; Greg A Volkmer; Shally H Wang; Yong Wang; Michael P Weiner; Pengguang Yu; Richard F Begley; Jonathan M Rothberg
Journal:  Nature       Date:  2005-07-31       Impact factor: 49.962

3.  Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy.

Authors:  Qiong Wang; George M Garrity; James M Tiedje; James R Cole
Journal:  Appl Environ Microbiol       Date:  2007-06-22       Impact factor: 4.792

4.  characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.

Authors:  G B Rogers; M P Carroll; D J Serisier; P M Hockey; G Jones; K D Bruce
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Versatile and open software for comparing large genomes.

Authors:  Stefan Kurtz; Adam Phillippy; Arthur L Delcher; Michael Smoot; Martin Shumway; Corina Antonescu; Steven L Salzberg
Journal:  Genome Biol       Date:  2004-01-30       Impact factor: 13.583

6.  Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections.

Authors:  Florence Fenollar; Véronique Roux; Andréas Stein; Michel Drancourt; Didier Raoult
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 7.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

8.  The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data.

Authors:  J R Cole; B Chai; R J Farris; Q Wang; A S Kulam-Syed-Mohideen; D M McGarrell; A M Bandela; E Cardenas; G M Garrity; J M Tiedje
Journal:  Nucleic Acids Res       Date:  2006-11-07       Impact factor: 16.971

9.  Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.

Authors:  Fadi Bittar; Hervé Richet; Jean-Christophe Dubus; Martine Reynaud-Gaubert; Nathalie Stremler; Jacques Sarles; Didier Raoult; Jean-Marc Rolain
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

10.  Comparative analysis of human gut microbiota by barcoded pyrosequencing.

Authors:  Anders F Andersson; Mathilda Lindberg; Hedvig Jakobsson; Fredrik Bäckhed; Pål Nyrén; Lars Engstrand
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more
  37 in total

Review 1.  The role of the bacterial microbiome in lung disease.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

Review 2.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

3.  Effect of sample storage conditions on culture-independent bacterial community measures in cystic fibrosis sputum specimens.

Authors:  Jiangchao Zhao; Jun Li; Patrick D Schloss; Linda M Kalikin; Tracy A Raymond; Joseph F Petrosino; Vincent B Young; John J LiPuma
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

4.  Changes of Intestinal Microecology in Patients with Primary Sjogren's Syndrome after Therapy of Yangyin Yiqi Huoxue Recipe ().

Authors:  Guo-Lin Wu; Hai-Feng Lu; Yi-Lian Chen; Qing Wang; Heng Cao; Tian-Yi Li
Journal:  Chin J Integr Med       Date:  2019-06-04       Impact factor: 1.978

Review 5.  Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs.

Authors:  Leopoldo N Segal; William N Rom; Michael D Weiden
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 6.  How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?

Authors:  Geraint B Rogers; Kenneth D Bruce; Lucas R Hoffman
Journal:  Curr Opin Pulm Med       Date:  2017-11       Impact factor: 3.155

7.  Spatial distribution of microbial communities in the cystic fibrosis lung.

Authors:  Dana Willner; Matthew R Haynes; Mike Furlan; Robert Schmieder; Yan Wei Lim; Paul B Rainey; Forest Rohwer; Douglas Conrad
Journal:  ISME J       Date:  2011-07-28       Impact factor: 10.302

8.  Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.

Authors:  Michael J Cox; Martin Allgaier; Byron Taylor; Marshall S Baek; Yvonne J Huang; Rebecca A Daly; Ulas Karaoz; Gary L Andersen; Ronald Brown; Kei E Fujimura; Brian Wu; Diem Tran; Jonathan Koff; Mary Ellen Kleinhenz; Dennis Nielson; Eoin L Brodie; Susan V Lynch
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

9.  Detection of plant DNA in the bronchoalveolar lavage of patients with ventilator-associated pneumonia.

Authors:  Sabri Bousbia; Laurent Papazian; Bernard La Scola; Didier Raoult
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

10.  Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.

Authors:  Raúl Cabrera-Rubio; Marian Garcia-Núñez; Laia Setó; Josep M Antó; Andrés Moya; Eduard Monsó; Alex Mira
Journal:  J Clin Microbiol       Date:  2012-08-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.